California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts The state awarded a $50 million contract to produce less [...] By digitalstudios|2023-03-24T15:25:37+00:00March 24, 2023|3rd Party Pharmaceutical Industry News|Comments Off on California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts Read More